SEC Form 4 · accession 0001140361-15-011531
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry Labinger
Officer — EVP, Biosciences Div.
Period of report
Mar 10, 2015
Accepted (ET)
Mar 12, 2015 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 10, 2015 | A | 10,762 | $0.00 | A | 38,387 | D | |
| Common StockF1 | Mar 10, 2015 | F | 1,594 | $29.00 | D | 36,793 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $28.99 | Mar 10, 2015 | A | 21,517 | A | — | Mar 9, 2022 | Common Stock | 21,517 | 21,517 | D |
Explanation of responses
- F1Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- F2These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- F3Vests in three equal installments on March 9, 2016, March 9, 2017 and March 9, 2018.